<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To study the loss of heterozygosity and the presence of mutations at the p53, p16/CDKN2, and APC genes in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, low grade dysplastic oesophageal epithelium, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the oesophagus; to relate the presence of alterations at these genes with the progression from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: DNA was extracted from paraffin blocks containing tissue from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (12 samples), low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (15 cases), and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (14 cases) </plain></SENT>
<SENT sid="2" pm="."><plain>Loss of heterozygosity (LOH) at the p53, p16, and APC genes was determined by comparing the autoradiographic patterns of several microsatellite markers between the <z:mpath ids='MPATH_458'>normal</z:mpath> tissue and the malignant tissue counterpart </plain></SENT>
<SENT sid="3" pm="."><plain>SSCP was used to determine the presence of mutations at p53 (exons 5 to 8), p16 (exon 2), and APC </plain></SENT>
<SENT sid="4" pm="."><plain>Homozygous deletion of the p16 gene was defined through polymerase chain reaction followed by Southern blot </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: LOH at the p53, p16, and APC genes was not observed in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and increased to 90% (p53), 89% (p16), and 60% (APC) in the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The p53 gene was mutated in only two <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (codons 175 and 245) </plain></SENT>
<SENT sid="7" pm="."><plain>In one case a mutation at the APC gene (codon 1297) was found </plain></SENT>
<SENT sid="8" pm="."><plain>No patient had mutation at the second exon of p16 </plain></SENT>
<SENT sid="9" pm="."><plain>However, this gene was homozygously deleted in three of the 12 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor genes p53, p16, and APC are often deleted in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> derived from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Mutations at these genes are also found in the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, including the homozygous deletion of the p16 gene </plain></SENT>
<SENT sid="12" pm="."><plain>However, the absence of genetic alterations in the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and the low grade dysplastic epithelia suggest that mutations at these genes develop later in the progression from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>